Status:
COMPLETED
Esophageal Hypersensitivity Study in Healthy Volunteers
Lead Sponsor:
AstraZeneca
Conditions:
Pain
Esophageal Sensitivity
Eligibility:
MALE
20-45 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to compare sensitivity and sensitization of visceral pain in the esophagus using different pain stimuli
Eligibility Criteria
Inclusion
- Provision of written consent
- Clinically normal physical findings
- Sensitization potential
Exclusion
- Clinically significant illness within 2 weeks prior to the first dose of investigational product
- History of clinically significant disease
- Use of prescribed medication during the 2 weeks before administration of the first dose of investigational product
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2009
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00711048
Start Date
June 1 2008
End Date
July 1 2009
Last Update
August 28 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Aarhus, Denmark
2
Research Site
Gothenburg, Sweden